733 related articles for article (PubMed ID: 30099654)
21. [Sensibility and specificity for pregnancy morbidity of anti-β2-glycoprotein I antibodies in antiphospholipid syndrome].
Tonello M; Ruffatti A; Favaro M; Del Ross T; Zamboni D; Grypiotis P; Cavazzana A; Ciprian M; Todesco S
Reumatismo; 2005 Dec; 57(4):262-6. PubMed ID: 16380753
[TBL] [Abstract][Full Text] [Related]
22. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
23. Distribution of lupus anticoagulant and anticardiolipin antibody isotypes in a population with antiphospholipid syndrome.
Guglielmone HA; Fernandez EJ
J Rheumatol; 1999 Jan; 26(1):86-90. PubMed ID: 9918246
[TBL] [Abstract][Full Text] [Related]
24. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
25. Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays.
Tsutsumi A; Hayashi T; Chino Y; Mamura M; Goto D; Matsumoto I; Ito S; Sumida T
Mod Rheumatol; 2006; 16(3):158-64. PubMed ID: 16767554
[TBL] [Abstract][Full Text] [Related]
26. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
29. Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies.
Forastiero RR; Martinuzzo ME; Cerrato GS; Kordich LC; Carreras LO
Thromb Haemost; 1997 Sep; 78(3):1008-14. PubMed ID: 9308745
[TBL] [Abstract][Full Text] [Related]
30. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?
Ghirardello A; Doria A; Ruffatti A; Rigoli AM; Vesco P; Calligaro A; Gambari PF
Ann Rheum Dis; 1994 Feb; 53(2):140-2. PubMed ID: 8129460
[TBL] [Abstract][Full Text] [Related]
31. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
Marai I; Levi Y; Godard G; Shoenfeld Y
Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
[TBL] [Abstract][Full Text] [Related]
32. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
[TBL] [Abstract][Full Text] [Related]
33. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
34. Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic risk.
Emmenegger M; Emmenegger V; Shambat SM; Scheier TC; Gomez-Mejia A; Chang CC; Wendel-Garcia PD; Buehler PK; Buettner T; Roggenbuck D; Brugger SD; Frauenknecht KBM
Clin Immunol; 2023 Dec; 257():109845. PubMed ID: 37995947
[TBL] [Abstract][Full Text] [Related]
35. A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis.
Forastiero R; Martinuzzo M; Pombo G; Puente D; Rossi A; Celebrin L; Bonaccorso S; Aversa L
J Thromb Haemost; 2005 Jun; 3(6):1231-8. PubMed ID: 15946213
[TBL] [Abstract][Full Text] [Related]
36. Double positivity of anti-β
Yun J; Gu J; Kim HK
J Thromb Thrombolysis; 2021 Nov; 52(4):1133-1136. PubMed ID: 33914240
[TBL] [Abstract][Full Text] [Related]
37. Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke.
Naranjo L; Ostos F; Gil-Etayo FJ; Hernández-Gallego J; Cabrera-Marante Ó; Pleguezuelo DE; Díaz-Simón R; Cerro M; Lora D; Martínez-Salio A; Serrano A
Front Cardiovasc Med; 2021; 8():665741. PubMed ID: 34012984
[No Abstract] [Full Text] [Related]
38. Characteristics of purified anti-β2GPI IgG N-glycosylation associate with thrombotic, obstetric and catastrophic antiphospholipid syndrome.
Liu T; Han J; Zhang R; Tang Z; Yi G; Gong W; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Shi Y; Gu J; Ren S; Yang C; Shi H
Rheumatology (Oxford); 2022 Mar; 61(3):1243-1254. PubMed ID: 34015111
[TBL] [Abstract][Full Text] [Related]
39. The clinical relevance of different antiphospholipid antibody profiles in pediatric rheumatology patients.
Pandya J; Onel K; Erkan D
Pediatr Rheumatol Online J; 2024 Apr; 22(1):46. PubMed ID: 38671480
[TBL] [Abstract][Full Text] [Related]
40. Clinical Relevance of Isolated Lupus Anticoagulant Positivity in Patients with Thrombotic Antiphospholipid Syndrome.
Yin D; de Groot PG; Ninivaggi M; Devreese KMJ; de Laat B
Thromb Haemost; 2021 Sep; 121(9):1220-1227. PubMed ID: 33385181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
